首页 | 本学科首页   官方微博 | 高级检索  
     


L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas
Authors:Gast Daniela  Riedle Svenja  Riedle Svenja  Schabath Heidi  Schlich Sabine  Schneider Annette  Issa Yasmin  Stoeck Alexander  Fogel Mina  Joumaa Safwan  Wenger Till  Herr Ingrid  Gutwein Paul  Altevogt Peter
Affiliation:Tumor Immunology Programme, D010, German Cancer Research Center, Heidelberg, Germany.
Abstract:
L1 is a neural cell adhesion molecule involved in cell migration, axon growth and guidance. Recent data have shown that L1 is overexpressed in ovarian and endometrial tumors and is associated with bad prognosis. How L1 promotes tumor progression is presently unknown. Here we show that L1 expression is predominantly confined to the invasive front of ovarian carcinomas. Overexpression of L1 in carcinoma cell lines by adenovirus-mediated gene transfer enhanced the haptotactic cell migration on extracellular matrix proteins. Expression of L1 augmented tumor growth of carcinomas xenografted in nonobese diabetic/severe combined immunodeficient mice (NOD/SCID). A recent report has demonstrated L1-dependent upregulation of beta3 integrin involving activation of the extracellular signal-regulated kinase (erk) pathway. We find that L1 and beta3 integrin are not coexpressed in ovarian carcinoma tissues. Overexpression of L1 did not upregulate beta3 integrin in ovarian carcinoma cell lines but could do so in HEK293 cells. Our results suggest that L1 could drive progression by enhancing cell migration and tumor growth but that L1 dependent and erk-regulated gene expression requires cell-type specific elements.
Keywords:L1  CD171  cell migration  ovarian carcinoma
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号